Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 47.80$. Average daily volumn in 3 months 17.58M. Market cap 245.60B



Stock symbol : PFE. Exchange : NYSE. Currency : USD
Lastest price : 43.76$. Total volume : 21.64M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Pfizer Inc. (PFE)
Last Price
43.76$
Change
-0.40
Volume
21.64M

Previous Close44.16
Open44.17
Day Range43.73-44.60
Bid43.83 x 3.2k
Ask44.02 x 2.2k
Volume21.64M
Average Volume17.58M
Market Cap245.6B
BetaN/A
52 Week Range40.94-61.71
Trailing P/E8.51
Foward P/E0.73
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to Pfizer Inc.'s financial reports the company's revenue in 2021 were 81.29B an increase( +97.56%) over the years 2020 revenue that were of 41.65B. In 2021 the company's total earnings were 21.98B while total earnings in 2020 were 9.16B( +133.33%).


Loading ...



Organization

Market Cap:
245.60B
Revenue:
81.29B
Total Assets:
181.48B
Total Cash:
1.94B


News about "Pfizer Inc."

gfs-advisors-llc-sells-32990-shares-of-pfizer-inc-nysepfe-image

GFS Advisors LLC Sells 32,990 Shares of Pfizer Inc. (NYSE:PFE)

Source from : Defense World - 1 days ago

GFS Advisors LLC lessened its holdings in Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 17.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 157,198 shares ...See details»


pfizer-inc-nysepfe-shares-sold-by-sippican-capital-advisors-image

Pfizer Inc. (NYSE:PFE) Shares Sold by Sippican Capital Advisors

Source from : Defense World - 1 days ago

Sippican Capital Advisors lessened its holdings in Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 0.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and ...See details»


pfizer-incs-nysepfe-earnings-are-not-doing-enough-for-some-investors-image

Pfizer Inc.'s (NYSE:PFE) Earnings Are Not Doing Enough For Some Investors

Source from : YAHOO!Finance - 2 days ago

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 14x, you ...See details»


pfizer-pfe-seeks-fda-approval-for-omicron-booster-in-kids-image

Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids

Source from : YAHOO!News - 3 days ago

Pfizer (PFE) and partner BioNTech seek authorization from the FDA for using their bivalent COVID-19 booster vaccine in kids. The vaccine is already authorized for use in adolescents and adults.See details»


Pfizer CEO tests positive for COVID for a second time

Source from : Reuters - 6 days ago

Sept 24 (Reuters) - Pfizer Inc (PFE.N) Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "Iโ€™m feeling well and symptom free," Bourla said in a statement.See details»


are-pfizer-incs-nysepfe-fundamentals-good-enough-to-warrant-buying-given-the-stocks-recent-weakness-image

Are Pfizer Inc.'s (NYSE:PFE) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Source from : Nasdaq - 9 days ago

It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined 8.9% over the past month. But if you pay close attention, you might find that its key ...See details»


Pfizer CEO Contracts COVID-19 Infection For Second Time

Source from : Yahoo News - 4 days ago

Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19. "I'm feeling well and symptom-free," 60-year-old Bourla said in a statement. In August, he contacted COVID and ...See details»


Pfizer: Covid-19 Treatment Isn't Only Expansion Opportunity On Deck

Source from : Seeking Alpha - 10 days ago

Pfizer Inc. (NYSE:PFE) is a great long-term biotech to own because it has two great long-term prospects that it is gearing towards. The first is the opportunity to increase sales with the use of ...See details»


Pfizer/BioNTech seek FDA nod for new COVID boosters for children

Source from : Reuters - 4 days ago

REUTERS/Hannah Beier/File Photo Sept 26 (Reuters) - Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron ...See details»


Pfizer Inc (PFE) Breaks Through Support at $44.85

Source from : MarketWatch - 10 days ago

Pfizer Inc (NYSE:PFE) has opened bearishly below the pivot of $45.37 today and has reached the first level of support at $44.85. Should the shares continue to fall, the support pivots of $44.27 and ...See details»


Pfizer Inc.'s (NYSE:PFE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Source from : Yahoo - 10 days ago

It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined 8.9% over the past month. But if you pay close attention, you might find that its key ...See details»


here-is-what-to-know-beyond-why-pfizer-inc-pfe-is-a-trending-stock-image

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Source from : Yahoo Finance - 2 days ago

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...See details»


Pfizer Requests Clearance for Childrenโ€™s Covid-19 Booster

Source from : Wall Street Journal - 4 days ago

Pfizer Inc. and BioNTech SE asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years. The companies made the request on Monday as retooled shots ...See details»


Pfizer, BioNTech Ask FDA to Approve Booster for Children

Source from : MarketWatch - 5 days ago

By Dean Seal Pfizer Inc. and partner BioNTech SE have asked the U.S. Food and Drug Administration to approve the use of its Omicron-specific Covid-19 ...See details»